Select Enterprise Value Over E B I T D A from 2010 to 2024

SEM Stock  USD 20.35  0.99  4.64%   
Select Medical Enterprise Value Over EBITDA yearly trend continues to be very stable with very little volatility. Enterprise Value Over EBITDA is likely to drop to 6.31. During the period from 2010 to 2024, Select Medical Enterprise Value Over EBITDA quarterly data regression pattern had sample variance of  3.48 and median of  7.92. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
8.42576413
Current Value
6.31
Quarterly Volatility
1.86500251
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Select Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Select Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 135.3 M, Interest Expense of 152.3 M or Total Revenue of 4.2 B, as well as many indicators such as Price To Sales Ratio of 0.21, Dividend Yield of 0.039 or PTB Ratio of 1.27. Select financial statements analysis is a perfect complement when working with Select Medical Valuation or Volatility modules.
  
Check out the analysis of Select Medical Correlation against competitors.

Latest Select Medical's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Select Medical Holdings over the last few years. It is Select Medical's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Select Medical's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Pretty Stable
   Enterprise Value Over E B I T D A   
       Timeline  

Select Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean7.94
Geometric Mean7.75
Coefficient Of Variation23.48
Mean Deviation1.39
Median7.92
Standard Deviation1.87
Sample Variance3.48
Range6.6047
R-Value0.16
Mean Square Error3.65
R-Squared0.02
Significance0.57
Slope0.07
Total Sum of Squares48.70

Select Enterprise Value Over E B I T D A History

2023 8.43
2022 11.44
2021 8.68
2020 8.57
2019 8.48
2018 6.75
2017 7.35

About Select Medical Financial Statements

Select Medical investors utilize fundamental indicators, such as Enterprise Value Over E B I T D A, to predict how Select Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA 8.43  6.31 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Select Medical Holdings is a strong investment it is important to analyze Select Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Select Medical's future performance. For an informed investment choice regarding Select Stock, refer to the following important reports:
Check out the analysis of Select Medical Correlation against competitors.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.139
Dividend Share
0.5
Earnings Share
2.14
Revenue Per Share
56.158
Quarterly Revenue Growth
0.057
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.